NCT03904524

Brief Summary

While interdisciplinary family meetings are evidence-based and part of usual care, this study seeks to test a novel set of implementation strategies (the SET-to-Meet intervention) to improve adherence to best practice guidelines for interdisciplinary family meetings. SET stands for Screen-Engage-Track; SET-to Meet is a nurse-led, team based intervention to ensure routine interdisciplinary family meetings are held on behalf of incapacitated, critically-ill patients in ICUs. This study is a feasibility and acceptability pilot test of the intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
97

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 27, 2019

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 5, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

June 13, 2019

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 5, 2020

Completed
3.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

May 8, 2024

Status Verified

May 1, 2024

Enrollment Period

1.1 years

First QC Date

March 27, 2019

Last Update Submit

May 6, 2024

Conditions

Keywords

Intensive Care UnitSerious Illness CommunicationClinician-Family CommunicationFamily Support

Outcome Measures

Primary Outcomes (5)

  • Feasibility of training the staff for the intervention, as measured by percent of staff members completing on-line training

    Feasibility of using online training will be assessed by percent of staff members who complete the on-line training during the two week training phase.

    At the completion of the two week training phase which will occur immediately prior to initiating the 3-month pilot of the intervention

  • Feasibility of patient recruitment at the site, as measured by the volume of eligible patients admitted to the pilot ICU during the pilot phase.

    Feasibility of recruitment will be assessed by the volume of eligible patient admitted to the pilot ICU.

    At the conclusion of the 3-month pilot

  • Adherence to elements of intervention protocol

    Adherence to steps in the intervention protocol for eligible patients will be assessed by review of tracking forms, questions to staff about patient screening and about engagement with family members, and direct observation of staff during interdisciplinary team rounds.

    Throughout the 3 month pilot phase

  • Acceptability of the intervention to clinicians assessed via focus groups

    Acceptability of the intervention will be evaluated using focus group sessions with physicians, social workers, care managers, and nurses. Using a semi-structured interview guide, we will elicit detailed information about staff satisfaction with the intervention; the clinician experience of participating in the intervention; staff-perceived value of the intervention to patients and families; and suggestions for improvement.

    At the conclusion of the 3-month pilot

  • Clinician Satisfaction with the intervention assessed via on-line survey

    Satisfaction of staff with: 1.) the intervention training and 2.) on-site support, as well as perceived value to patients/families and perceived burden of carrying out the intervention will be evaluated using a multi-item, likert-scale scored online survey sent to physicians, social workers, care managers, and nurses.

    At the conclusion of the 3-month pilot

Secondary Outcomes (2)

  • Proportion of patients with a family meeting

    At the conclusion of the 3-month pilot

  • Time elapsed until the first family meeting

    At the conclusion of the 3-month pilot

Study Arms (1)

SET-to-MEET

EXPERIMENTAL

This is a single arm, open trial that will be conducted in parallel in 3 separate ICUs. Each site will receive the SET-to-MEET intervention.

Behavioral: SET-to-Meet

Interventions

SET-to-MeetBEHAVIORAL

The overall objective of this study is to pilot test, in advance of a larger randomized trial, a scalable, nurse-led intervention to ensure timely interdisciplinary family meetings are held on behalf of critically-ill ICU patients who cannot participate in discussions about their care.

SET-to-MEET

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients: Individuals ≥18 year of age, admitted to the ICU for intensive care services at one of the 3 pilot sites during the pilot testing phase.
  • Pilot site clinicians: nurses, care managers, social workers, and physicians who are employed/provide services in the pilot site.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Excela Westmoreland Hospital

Greensburg, Pennsylvania, 15601, United States

Location

West Penn Hospital

Pittsburgh, Pennsylvania, 15224, United States

Location

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Jennifer B Seaman, PhD,RN,CHPN

    University of Pittsburgh School of Nursing

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, School of Nursing

Study Record Dates

First Submitted

March 27, 2019

First Posted

April 5, 2019

Study Start

June 13, 2019

Primary Completion

August 5, 2020

Study Completion

December 31, 2023

Last Updated

May 8, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

This study will be conducted at sites within two different health systems, Allegheny Health Network and Excela Health, each with their own Institutional Review Board (IRB). The data use agreements with those respective organizations are pending, and we do not yet know the conditions and specifically, if and under what circumstances data sharing will be permitted. Provided data sharing is permitted, and in accordance with those agreements, academic collaborators of the Principal Investigator outside of the University of Pittsburgh may have access to participant data collected during the trial, after de-identification. These outside collaborators will obtain their own IRB approval for their role.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
These will be made available beginning 9 months and ending 36 months following article publication.
Access Criteria
We will make this data available to collaborators whose proposed use of the data has been approved by an independent review committee.

Locations